{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T20:20:42Z","timestamp":1787516442277,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K14795"],"award-info":[{"award-number":["JP24K14795"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.imlet.2026.107227","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:20:12Z","timestamp":1786429212000},"page":"107227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["S-equol shifts afatinib-altered mucosal immune\u2013epithelial defense indices toward baseline and attenuates increases in DEFA5 and SOX9 promoter methylation indices"],"prefix":"10.1016","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9457-3127","authenticated-orcid":false,"given":"Ippei","family":"Uemura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6097-948X","authenticated-orcid":false,"given":"Takashi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Takahashi-Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2026.107227_bib0001","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","article-title":"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","volume":"16","author":"Yang","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.imlet.2026.107227_bib0002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-018-05102-x","article-title":"The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea","volume":"175","author":"Rugo","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.imlet.2026.107227_bib0003","doi-asserted-by":"crossref","first-page":"252","DOI":"10.21037\/tlcr-20-649","article-title":"A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401","volume":"10","author":"Okajima","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.imlet.2026.107227_bib0004","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.2147\/OTT.S145613","article-title":"Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer","volume":"10","author":"Ichiki","year":"2017","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.imlet.2026.107227_bib0005","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126444","article-title":"Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea","volume":"4","author":"Duan","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.imlet.2026.107227_bib0006","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrmicro2546","article-title":"Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis","volume":"9","author":"Bevins","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.imlet.2026.107227_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0105-2896.2005.00278.x","article-title":"The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces","volume":"206","author":"Kaetzel","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2026.107227_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.imlet.2026.107227_bib0009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ni.1825","article-title":"Enteric defensins are essential regulators of intestinal microbial ecology","volume":"11","author":"Salzman","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2026.107227_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1248\/bpb.b23-00672","article-title":"Regulation of chloride channels by epidermal growth factor receptor-tyrosine kinase inhibitor-induced \u03b1-defensin 5","volume":"47","author":"Uemura","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.imlet.2026.107227_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.107024","article-title":"Impact of afatinib on intestinal and salivary IgA: immune response alterations linked to gastrointestinal side effects","volume":"275","author":"Uemura","year":"2025","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2026.107227_bib0012","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.3748\/wjg.v19.i32.5238","article-title":"DNA methylation in inflammatory bowel disease and beyond","volume":"19","author":"Low","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.imlet.2026.107227_bib0013","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.stem.2024.08.006","article-title":"Inflammation-induced epigenetic imprinting regulates intestinal stem cells","volume":"31","author":"Zhao","year":"2024","journal-title":"Cell Stem. Cell"},{"key":"10.1016\/j.imlet.2026.107227_bib0014","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cels.2024.08.007","article-title":"Promoter DNA methylation and transcription factor condensation are linked to transcriptional memory in mammalian cells","volume":"15","author":"Fan","year":"2024","journal-title":"Cell Syst."},{"key":"10.1016\/j.imlet.2026.107227_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2026.106217","article-title":"Epigenetic regulation of intestinal innate immunity during differentiation of Caco-2 cells under inflammatory stress","volume":"113","author":"Uemura","year":"2026","journal-title":"Toxicol. In Vitro."},{"key":"10.1016\/j.imlet.2026.107227_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2026.101146","article-title":"Afatinib alters DNA methylation and Paneth-like differentiation markers in Caco-2 cells","volume":"100","author":"Uemura","year":"2026","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.imlet.2026.107227_bib0017","doi-asserted-by":"crossref","first-page":"1355S","DOI":"10.3945\/jn.109.119776","article-title":"Equol: history, chemistry, and formation","volume":"140","author":"Setchell","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.imlet.2026.107227_bib0018","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/ajcn\/81.5.1072","article-title":"S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora","volume":"81","author":"Setchell","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.imlet.2026.107227_bib0019","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.bmc.2003.11.035","article-title":"Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta","volume":"12","author":"Muthyala","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.imlet.2026.107227_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108910","article-title":"Soy isoflavone metabolite equol inhibits cancer cell proliferation in a PAP-associated domain-containing 5-dependent and estrogen receptor-independent manner","volume":"100","author":"Yamashita","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.imlet.2026.107227_bib0021","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1017\/S000711451100657X","article-title":"Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines","volume":"108","author":"Bosviel","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.imlet.2026.107227_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2024.102952","article-title":"Establishment of an in-vitro inflammatory bowel disease model using immunological differentiation of Caco-2 cells","volume":"13","author":"Uemura","year":"2024","journal-title":"MethodsX"},{"key":"10.1016\/j.imlet.2026.107227_bib0024","unstructured":"Ministry of Health, Labour and Welfare of Japan, Q&A on soy and soy isoflavones: background and publication of the FSC report, 2006. https:\/\/www.mhlw.go.jp\/houdou\/2006\/02\/h0202-1.html (accessed May 7, 2026)."},{"key":"10.1016\/j.imlet.2026.107227_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.imlet.2026.107227_bib0026","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.fct.2008.04.026","article-title":"Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae","volume":"46","author":"Yee","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.imlet.2026.107227_bib0027","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1248\/bpb.b18-00338","article-title":"Gamma-aminobutyric acid (GABA) attenuates ischemia reperfusion-induced alterations in intestinal immunity","volume":"41","author":"Kubota","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.imlet.2026.107227_bib0028","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jep.2017.12.010","article-title":"Reishi mushroom Ganoderma lucidum modulates IgA production and alpha-defensin expression in the rat small intestine","volume":"214","author":"Kubota","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.imlet.2026.107227_bib0029","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/rpd\/ncae063","article-title":"Effects of low-dose rate radiation on immune and epigenetic regulation of the mouse testes","volume":"200","author":"Uemura","year":"2024","journal-title":"Radiat. Prot. Dosim."},{"key":"10.1016\/j.imlet.2026.107227_bib0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1189\/jlb.1005556","article-title":"Paneth cells: leukocyte-like mediators of innate immunity in the intestine","volume":"80","author":"Keshav","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2026.107227_bib0031","first-page":"10","article-title":"Analysis of risk factors for abemaciclib-induced diarrhea","volume":"52","author":"Takeuchi","year":"2026","journal-title":"Iryo Yakugaku"},{"key":"10.1016\/j.imlet.2026.107227_bib0032","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1196\/annals.1384.012","article-title":"Do salivary antibodies reliably reflect both mucosal and systemic immunity?","volume":"1098","author":"Brandtzaeg","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2026.107227_bib0033","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2188\/jea.JE20090185","article-title":"Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults","volume":"20","author":"Liu","year":"2010","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.imlet.2026.107227_bib0034","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3945\/jn.113.179564","article-title":"Dietary factors influence production of the soy isoflavone metabolite S-(\u2212)equol in healthy adults","volume":"143","author":"Setchell","year":"2013","journal-title":"J. Nutr."},{"key":"10.1016\/j.imlet.2026.107227_bib0035","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/jn\/136.8.2188","article-title":"Method of defining equol-producer status and its frequency among vegetarians","volume":"136","author":"Setchell","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.imlet.2026.107227_bib0036","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1079\/BJN20051565","article-title":"High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart","volume":"94","author":"Frankenfeld","year":"2005","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.imlet.2026.107227_bib0037","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jn\/136.5.1347","article-title":"Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls","volume":"136","author":"Song","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.imlet.2026.107227_bib0038","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/nu11020433","article-title":"Daidzein intake is associated with equol-producing status through an increase in the intestinal bacteria responsible for equol production","volume":"11","author":"Iino","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.imlet.2026.107227_bib0039","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1099\/ijs.0.65404-0","article-title":"Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella","volume":"58","author":"Maruo","year":"2008","journal-title":"Int. J. Syst. Evol. Microbiol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782600101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782600101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T19:25:43Z","timestamp":1787513143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524782600101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":38,"alternative-id":["S016524782600101X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107227","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-equol shifts afatinib-altered mucosal immune\u2013epithelial defense indices toward baseline and attenuates increases in DEFA5 and SOX9 promoter methylation indices","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107227"}}